Kenneth C Kalunian

Kenneth C Kalunian

UNVERIFIED PROFILE

Are you Kenneth C Kalunian?   Register this Author

Register author
Kenneth C Kalunian

Kenneth C Kalunian

Publications by authors named "Kenneth C Kalunian"

Are you Kenneth C Kalunian?   Register this Author

43Publications

1483Reads

-Profile Views

Construction of a frailty index as a novel health measure in systemic lupus erythematosus.

J Rheumatol 2019 Apr 15. Epub 2019 Apr 15.

Department of Medicine, Division of Rheumatology, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Community Health & Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada; Division of Geriatric Medicine, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea;Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Instituto Nacional de Ciencias Medicas y Nutrición, Mexico City, Mexico; Cedars-Sinai/David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; Divisions of Rheumatology and Clinical Epidemiology, Department of Medicine, McGill University, Montreal, Quebec, Canada; Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA; Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY, USA; Division of Rheumatology, CHU de Québec et Université Laval, Quebec City, Canada; Center for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, ON, Canada; Arthritis Research UK Epidemiology Unit, Faculty of Biology Medicine and Health, Manchester Academic Health Sciences Center, The University of Manchester, and NIHR Manchester Musculoskeletal Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Center Manchester, UK; Center for Rheumatology, Department of Medicine, University College London, UK; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, King's College London School of Medicine, UK, London, UK; Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, USA; Northwestern University and Feinberg School of Medicine, Chicago, IL, USA; Lupus Center of Excellence, Allegheny Health Network, Pittsburgh, PA, USA; Lanarkshire Center for Rheumatology, Hairmyres Hospital, East Kilbride, Scotland UK; Feinstein Institute for Medical Research, Manhasset, NY, USA; Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain; Emory University School of Medicine, Division of Rheumatology, Atlanta, Georgia, USA Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Unit for clinical therapy research (ClinTRID), Karolinska Institute, Stockholm, Sweden; Department of Clinical Sciences Lund, Rheumatology, Lund University, Lund, Sweden. Josep Font Autoimmune Diseases Laboratory, IDIBAPS, Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain; Medical University of South Carolina, Charleston, South Carolina, USA; UCSD School of Medicine, La Jolla, CA, USA; Copenhagen Lupus and Vasculitis Clinic, 4242, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; University of Manitoba, Winnipeg, Manitoba, Canada; Hospital for Joint Diseases, NYU, Seligman Center for Advanced Therapeutics, New York NY; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada. Funding for this work was provided by the Nova Scotia Health Authority Research Fund. Dr. Sang-Cheol Bae's work was supported in part by NRF-2017M3A9B4050335, Republic of Korea. Dr. Caroline Gordon's work was supported by Lupus UK and the NIHR /Wellcome Trust Clinical Research Facility. The Montreal General Hospital Lupus Clinic is partially supported by the Singer Family Fund for Lupus Research. Dr. Clarke holds The Arthritis Society Chair in Rheumatic Diseases at the University of Calgary. Dr. Paul R. Fortin presently holds a tier 1 Canada Research Chair on Systemic Autoimmune Rheumatic Diseases at Université Laval, and part of this work was done while he was still holding a Distinguished Senior Investigator of The Arthritis Society. Dr. Bruce is a National Institute for Health Research (NIHR) Senior Investigator and is supported by Arthritis Research UK, the NIHR Manchester Biomedical Centre and the NIHR/Wellcome Trust Manchester Clinical Research Facility. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. Dr Isenberg and Dr Rahman are supported by and supported by the National Institute for Health, Research University College London Hospitals Biomedical Research Center. The Hopkins Lupus Cohort is supported by the NIH (grant AR43727 and 69572). Dr. Mary Anne Dooley's work was supported by the NIH (grant RR00046). Dr. Ramsey-Goldman's work was supported by the NIH (grants 5UL1TR001422-02, formerly 8UL1TR000150 and UL-1RR-025741, K24-AR-02318, and P60AR064464 formerly P60-AR- 48098). Dr. Ruiz-Irastorza is supported by the Department of Education, Universities and Research of the Basque Government. Dr. Soren Jacobsen is supported by the Danish Rheumatism Association (A3865) and the Novo Nordisk Foundation (A05990). Dr. John G. Hanly is supported by the Canadian Institutes of Health Research (grant MOP-88526). Address Correspondence to: Dr. John G Hanly, Division of Rheumatology, Nova Scotia Rehabilitation Centre (2nd Floor), 1341 Summer Street, Halifax, Nova Scotia, Canada, B3H 4K4.Email:

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.181338
Publisher Site
http://dx.doi.org/10.3899/jrheum.181338DOI Listing
April 2019

Arthroscopy in Rheumatology: Time for a New Look?

J Rheumatol 2018 Mar;45(3):300-301

Department of Medicine, Division of Rheumatology, Allergy and Immunology, University of California at San Diego, San Diego, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.170397DOI Listing
March 2018

Current advances in therapies for osteoarthritis.

Curr Opin Rheumatol 2016 May;28(3):246-50

University of California, San Diego, La Jolla, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/BOR.0000000000000273DOI Listing
May 2016

CXCL13: a novel biomarker of B-cell return following rituximab treatment and synovitis in patients with rheumatoid arthritis.

Rheumatology (Oxford) 2011 Mar 23;50(3):603-10. Epub 2010 Nov 23.

Division of Rheumatology, Department of Medicine, Allergy and Immunology, University of California at San Diego School of Medicine, 9500 Gilman Drive, Mail Code 0656, La Jolla, CA 92093-0656, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/keq337DOI Listing
March 2011

Inflammatory characteristics on ultrasound predict poorer longterm response to intraarticular corticosteroid injections in knee osteoarthritis.

J Rheumatol 2010 Mar 15;37(3):650-5. Epub 2010 Jan 15.

University of California San Diego School of Medicine, 9350 Campus Point Drive, La Jolla, CA 92037, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.090575DOI Listing
March 2010

Elevated autoantibody content in rheumatoid arthritis synovia with lymphoid aggregates and the effect of rituximab.

Arthritis Res Ther 2008 1;10(5):R105. Epub 2008 Sep 1.

Division of Rheumatology, Allergy and Immunology, University of California at San Diego School of Medicine, 9500 Gilman Drive, La Jolla, CA 92093, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1186/ar2497.pdf
Web Search
http://arthritis-research.com/content/10/5/R105
Publisher Site
http://dx.doi.org/10.1186/ar2497DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592782PMC
February 2009

New developments in osteoarthritis.

Rheum Dis Clin North Am 2007 Feb;33(1):135-48

Center of Innovative Therapies, University of California at San Diego, 9320 Campus Point Drive, Suite 225, La Jolla, CA 92037-0943, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rdc.2006.12.003DOI Listing
February 2007

The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis.

J Rheumatol 2007 Jan;34(1):123-9

Division of Rheumatology, Allergy and Immunology, University of California, San Diego, San Diego, California, USA.

View Article

Download full-text PDF

Source
January 2007

New developments in osteoarthritis.

Clin Geriatr Med 2005 Aug;21(3):589-601, vii

Center of Innovative Therapies at the University of San Diego at California, 9320 Campus Point Drive, Suite 225, La Jolla, CA 92037-0943, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cger.2005.02.008DOI Listing
August 2005

Calcium-containing crystals and osteoarthritis: implications for the clinician.

Curr Rheumatol Rep 2005 Jun;7(3):213-9

University of California San Diego, Division of Rheumatology and Allergy-Immunology, 9320 Campus Point Drive #227, La Jolla, CA 92037, USA. .

View Article

Download full-text PDF

Source
June 2005

Defining response in systemic lupus erythematosus: a study by the Systemic Lupus International Collaborating Clinics group.

J Rheumatol 2004 Dec;31(12):2390-4

Division of Rheumatology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
December 2004

Linkage and interaction of loci on 1q23 and 16q12 may contribute to susceptibility to systemic lupus erythematosus.

Arthritis Rheum 2002 Nov;46(11):2928-36

Department of Medicine, Rehabilitation Center, Room 32-59, 1000 Veteran Avenue, UCLA School of Medicine, Los Angeles, CA 90095-1670, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.10590DOI Listing
November 2002

Familiality and co-occurrence of clinical features of systemic lupus erythematosus.

Arthritis Rheum 2002 Oct;46(10):2678-85

Division of Rheumatology, Department of Medicine, Rehabilitation Center, Room 32-59, University of California-Los Angeles School of Medicine, 1000 Veteran Avenue, Los Angeles, CA 90095-1670, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.10519DOI Listing
October 2002